Treatment with the Bcl-xL inhibitor ABT-737 in combination with interferon α specifically targets JAK2V617F-positive polycythemia vera hematopoietic progenitor cells (Q34360366)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment with the Bcl-xL inhibitor ABT-737 in combination with interferon α specifically targets JAK2V617F-positive polycythemia vera hematopoietic progenitor cells |
scientific article |
Statements
1 reference
Treatment with the Bcl-xL inhibitor ABT-737 in combination with interferon α specifically targets JAK2V617F-positive polycythemia vera hematopoietic progenitor cells (English)
1 reference
John Mascarenhas
1 reference
Min Lu
1 reference
Jiapeng Wang
1 reference
Yan Li
1 reference
Dmitriy Berenzon
1 reference
Xiaoli Wang
1 reference
Mingjiang Xu
1 reference
Ronald Hoffman
1 reference
12 July 2010
1 reference
1 reference
116
1 reference
20
1 reference
4284-4287
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference